ABBV vs BOW · P/E 81, rev $61.16B vs P/E 16, rev $425.7M
AbbVie Inc (ABBV) versus Bowhead Specialty Holdings Inc. (BOW) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Bowhead Specialty Holdings Inc. (BOW) is a insurance - property & casualty company listed on NYSE.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported BOW revenue for 2024-12-31 was $425.7M. Net income was $38.2M. Revenue was up 50.2% from 2023-12-31 to 2024-12-31. BOW currently screens at market cap $903.7M and trailing P/E 15.9.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. BOW currently screens at market cap $903.7M and trailing P/E 15.9.
Not investment advice. Open the ABBV and BOW stock pages for the full models.
Not investment advice.